Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
SILV - SilverCrest Metals Inc - Stock Price Chart
TickerSILV [AMEX]
CompanySilverCrest Metals Inc
CountryCanada
IndustryOther Precious Metals & Mining
Market Cap1.35BEPS (ttm)0.83
P/E11.05EPS this Y-39.49%
Forward P/E22.66EPS next Y-15.06%
PEG-EPS past 5Y-
P/S5.40EPS next 5Y-
P/B3.09EPS Q/Q28.45%
Dividend-Sales Q/Q9.77%
Insider Own2.59%Inst Own56.08%
Insider Trans0.00%Inst Trans-
Short Float6.97%EarningsMay 14/a
Analyst Recom1.88Target Price7.83
Avg Volume1.72M52W Range4.16 - 8.75
SilverCrest Metals, Inc. engages in the exploration, acquisition, and development of mineral properties and precious metals. It focuses on new discoveries, value-added acquisitions, and targeting production in Mexico's historic precious metal districts. The firm's portfolio includes Las Chispas, Cruz de Mayo, and El Picacho. The company was founded on June 23, 2015, and is headquartered in Vancouver, Canada.
CAMT - Camtek Ltd - Stock Price Chart
TickerCAMT [NASD]
CompanyCamtek Ltd
CountryIsrael
IndustrySemiconductor Equipment & Materials
Market Cap4.50BEPS (ttm)1.76
P/E56.56EPS this Y32.66%
Forward P/E32.78EPS next Y17.09%
PEG4.88EPS past 5Y25.47%
P/S13.25EPS next 5Y11.60%
P/B10.16EPS Q/Q43.26%
Dividend0.67%Sales Q/Q33.89%
Insider Own38.74%Inst Own50.40%
Insider Trans0.00%Inst Trans-0.86%
Short Float8.00%EarningsMay 09/b
Analyst Recom1.12Target Price106.12
Avg Volume439.61K52W Range26.56 - 95.13
Camtek Ltd. engages in the business of developing and manufacturing high-end inspection and metrology equipment for the semiconductor industry. The firm is also involved in inspecting integrated circuits and measuring its features on wafers throughout the production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly. The company was founded on October 21, 1987 and is headquartered in Migdal HaEmek, Israel.
TPC - Tutor Perini Corp - Stock Price Chart
TickerTPC [NYSE, RUT]
CompanyTutor Perini Corp
CountryUSA
IndustryEngineering & Construction
Market Cap1.05BEPS (ttm)-2.05
P/E-EPS this Y129.59%
Forward P/E13.34EPS next Y53.46%
PEG-EPS past 5Y-
P/S0.25EPS next 5Y10.00%
P/B0.80EPS Q/Q131.45%
Dividend-Sales Q/Q35.13%
Insider Own18.35%Inst Own63.72%
Insider Trans-3.71%Inst Trans-0.84%
Short Float3.64%EarningsApr 25/a
Analyst Recom2.00Target Price15.50
Avg Volume453.77K52W Range5.05 - 19.56
Tutor Perini Corp. engages in the provision of construction services. It operates through the following business segments: Civil, Building, and Specialty Contractors. The Civil segment specializes in public works construction and the replacement and reconstruction of infrastructure across the major geographic regions of the United States. The Building segment offers services to a number of specialized building markets for private and public works customers, including hospitality and gaming, transportation, health care, commercial offices, government facilities, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high-tech. The Specialty Contractors segment covers electrical, mechanical, plumbing, HVAC, fire protection systems and pneumatically placed concrete for a full range of civil and building construction projects in the industrial, commercial, hospitality and gaming, and mass-transit end markets. The company was founded by Bonfiglio Perini in 1918 and is headquartered in Sylmar, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SMALLEY GARY G.PresidentMar 20 '24Sale13.2815,940211,68368,346Mar 20 05:50 PM
SMALLEY GARY G.PresidentMar 19 '24Sale13.0227,959364,02684,286Mar 20 05:50 PM
SMALLEY GARY G.PresidentMar 18 '24Sale12.8627,958359,540112,245Mar 20 05:50 PM
SMALLEY GARY G.PresidentMar 15 '24Sale12.6320,304256,440140,203Mar 15 07:32 PM
SMALLEY GARY G.PresidentMar 14 '24Sale12.4020,303251,757160,507Mar 15 07:32 PM
CRDL - Cardiol Therapeutics Inc - Stock Price Chart
TickerCRDL [NASD]
CompanyCardiol Therapeutics Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap157.70MEPS (ttm)-0.34
P/E-EPS this Y5.69%
Forward P/E-EPS next Y0.32%
PEG-EPS past 5Y16.52%
P/S-EPS next 5Y-
P/B10.64EPS Q/Q-23.72%
Dividend-Sales Q/Q-
Insider Own4.73%Inst Own8.72%
Insider Trans0.00%Inst Trans-
Short Float0.50%EarningsApr 01/a
Analyst Recom1.00Target Price5.43
Avg Volume416.40K52W Range0.55 - 2.25
Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.
THRD - Third Harmonic Bio Inc - Stock Price Chart
TickerTHRD [NASD, RUT]
CompanyThird Harmonic Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap529.47MEPS (ttm)-0.95
P/E-EPS this Y-68.92%
Forward P/E-EPS next Y-28.37%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.94EPS Q/Q41.33%
Dividend-Sales Q/Q-
Insider Own38.64%Inst Own41.99%
Insider Trans-0.33%Inst Trans-
Short Float8.20%EarningsMay 15/b
Analyst Recom2.00Target Price9.55
Avg Volume154.67K52W Range4.31 - 13.00
Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holles Natalie C.CEOMay 09 '24Option Exercise4.2020,22284,9321,239,058May 10 04:04 PM
Holles Natalie C.CEOMay 09 '24Sale12.1820,222246,3001,218,836May 10 04:04 PM
Holles Natalie C.CEOApr 11 '24Option Exercise4.2013,55856,9441,232,394Apr 15 04:14 PM
Holles Natalie C.CEOApr 11 '24Sale12.1913,558165,2141,218,836Apr 15 04:14 PM
Person JulieCHIEF ADMINISTRATIVE OFFICERApr 04 '24Option Exercise4.201,1074,6491,107Apr 08 05:21 PM
HUMA - Humacyte Inc - Stock Price Chart
TickerHUMA [NASD, RUT]
CompanyHumacyte Inc
CountryUSA
IndustryBiotechnology
Market Cap802.60MEPS (ttm)-1.01
P/E-EPS this Y11.21%
Forward P/E-EPS next Y18.95%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B30.69EPS Q/Q17.68%
Dividend-Sales Q/Q-
Insider Own24.49%Inst Own15.89%
Insider Trans0.00%Inst Trans-9.29%
Short Float5.00%EarningsMay 10/b
Analyst Recom1.40Target Price8.00
Avg Volume1.51M52W Range1.96 - 6.62
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dougan Brady WDirectorOct 10 '23Option Exercise1.19114,420136,1601,384,660Oct 10 04:11 PM
Niklason Laura EPresident, CEO and DirectorOct 10 '23Option Exercise1.19114,420136,1601,384,660Oct 10 04:08 PM
Niklason Laura EPresident, CEO and DirectorSep 14 '23Sale2.782,000,0005,560,0006,191,140Sep 15 04:06 PM
Dougan Brady WDirectorSep 14 '23Sale2.782,000,0005,560,0006,191,140Sep 15 04:05 PM
Niklason Laura EPresident, CEO and DirectorAug 21 '23Sale3.39602,4432,042,2828,191,140Aug 21 06:07 PM
CDRO - Codere Online Luxembourg S.A - Stock Price Chart
TickerCDRO [NASD]
CompanyCodere Online Luxembourg S.A
CountryLuxembourg
IndustryGambling
Market Cap346.32MEPS (ttm)-
P/E-EPS this Y157.05%
Forward P/E23.53EPS next Y276.51%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B14.75EPS Q/Q86.41%
Dividend-Sales Q/Q108.09%
Insider Own67.74%Inst Own10.42%
Insider Trans0.00%Inst Trans-
Short Float1.51%EarningsFeb 29/b
Analyst Recom1.67Target Price10.02
Avg Volume42.17K52W Range2.68 - 8.09
Codere Online Luxembourg SA provides online sports betting and online casino services. It operates through the following segments: Spain, Mexico, Colombia, Other Operations, and Supporting Entities. The Spain segment consists of the revenue generated by CDON. The Mexico segment comprises of the AenP pursuant to the AenP Agreement. The Colombia segment refers to revenue generated by Codere Online Colombia S.A.S. The Other Operations segment includes Panama, Italy, Malta, Israel, and Gibraltar. The Supporting Entities segment covers the revenue generated by Codere Online Management Services Limited, Codere Israel Marketing Support Services LTD, Codere Online Luxembourg S.A., Codere Online U.S. Corp., Codere (Gibraltar) Marketing Services LTD, Servicios de Juego Online S.A.U. and Surviving Corporation. The company was founded in 2014 and is headquartered in Luxembourg.
RNA - Avidity Biosciences Inc - Stock Price Chart
TickerRNA [NASD, RUT]
CompanyAvidity Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap2.83BEPS (ttm)-2.95
P/E-EPS this Y-8.78%
Forward P/E-EPS next Y-5.75%
PEG-EPS past 5Y-57.60%
P/S260.14EPS next 5Y-
P/B3.40EPS Q/Q-6.13%
Dividend-Sales Q/Q58.67%
Insider Own10.48%Inst Own86.34%
Insider Trans-3.51%Inst Trans-0.74%
Short Float13.30%EarningsMay 09/a
Analyst Recom1.00Target Price45.25
Avg Volume1.18M52W Range4.82 - 29.10
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boyce SarahPresident and CEOMay 07 '24Option Exercise1.2428,00034,720140,117May 07 09:52 PM
Boyce SarahPresident and CEOMay 07 '24Sale25.5428,000715,050112,117May 07 09:52 PM
LEVIN ARTHUR ADirectorApr 19 '24Option Exercise1.245,0006,20019,830Apr 22 05:28 PM
LEVIN ARTHUR ADirectorApr 19 '24Sale22.825,000114,12314,830Apr 22 05:28 PM
LEVIN ARTHUR ADirectorApr 03 '24Sale27.1120,000542,214253,872Apr 03 08:26 PM
AGYS - Agilysys, Inc - Stock Price Chart
TickerAGYS [NASD, RUT]
CompanyAgilysys, Inc
CountryUSA
IndustrySoftware - Application
Market Cap2.62BEPS (ttm)3.16
P/E30.36EPS this Y13.18%
Forward P/E55.63EPS next Y38.35%
PEG607.15EPS past 5Y-
P/S11.04EPS next 5Y0.05%
P/B11.09EPS Q/Q-20.12%
Dividend-Sales Q/Q17.63%
Insider Own5.28%Inst Own91.87%
Insider Trans-54.92%Inst Trans-0.43%
Short Float2.03%EarningsMay 13/a
Analyst Recom1.00Target Price100.00
Avg Volume188.76K52W Range62.00 - 92.35
Agilysys, Inc. operates as a technology company. It offers innovative software for point-of-sale, payment gateway, reservation and table management, guest offers management, property management, inventory and procurement, analytics, document management, and mobile and wireless solutions and services to the hospitality industry. The firm also serves the gaming industry for both corporate and tribal, hotels resort and cruise, foodservice management, and the restaurant, university, and healthcare sectors. The company was founded in 1963 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SRINIVASAN RAMESHPresident & CEOMar 10 '24Option Exercise76.5311,309865,478643,060Mar 11 06:57 PM
KEATING MELVIN LDirectorMar 05 '24Buy75.951007,59644,039Mar 07 04:39 PM
KEATING MELVIN LDirectorFeb 20 '24Buy77.6230023,28743,939Feb 22 04:41 PM
MAK CAPITAL ONE LLC10% OwnerFeb 14 '24Sale82.59867,72971,665,7382,060,458Feb 16 07:41 PM
Wood William David IIIChief Financial OfficerJan 29 '24Sale85.4510,000854,50050,391Jan 31 05:04 PM
BROS - Dutch Bros Inc - Stock Price Chart
TickerBROS [NYSE]
CompanyDutch Bros Inc
CountryUSA
IndustryRestaurants
Market Cap3.59BEPS (ttm)0.18
P/E205.06EPS this Y19.03%
Forward P/E83.79EPS next Y26.02%
PEG7.19EPS past 5Y-53.03%
P/S3.44EPS next 5Y28.50%
P/B8.43EPS Q/Q224.93%
Dividend-Sales Q/Q39.46%
Insider Own15.19%Inst Own50.95%
Insider Trans-67.25%Inst Trans8.32%
Short Float10.23%EarningsMay 07/a
Analyst Recom1.71Target Price38.01
Avg Volume2.59M52W Range22.67 - 36.32
Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Grants Pass, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sullivan Sean B.A.DirectorMay 14 '24Option Exercise0.001,61201,612May 15 12:05 PM
Cone C. DavidDirectorMay 14 '24Option Exercise0.001,61201,612May 15 12:07 PM
Miller Ann MDirectorMay 14 '24Option Exercise0.0093806,496May 15 12:08 PM
Gillett StephenDirectorMay 14 '24Option Exercise0.00938013,679May 15 12:10 PM
George KathrynDirectorMay 14 '24Option Exercise0.0093809,293May 15 12:11 PM
12345671020